Best Medical Billing Companies for Infectious Disease Practices in Georgia 2026

Physician billing generally covers professional services provided by physicians or advanced practice providers, such as office visits, hospital consultations, and certain cognitive services. Hospital billing usually addresses facility resources and institutional services. Infectious disease practices may work alongside hospitals while separately billing professional services, infusion administration, drugs, or contracted coverage work. Reviewing each agreement, payer rule, documentation requirement, and service line helps clarify responsibility and reimbursement.

A collection process commonly begins with eligibility and benefit verification, authorization when required, accurate documentation and charge capture, coding review, claim submission, and rejection correction. After adjudication, the practice posts payments, reconciles expected reimbursement, follows up on unpaid or denied claims, appeals when appropriate, and works remaining balances. For infectious disease practices, tracking drug, infusion, hospital consult, and outpatient claims separately can reveal where collection problems originate.

Infectious disease billing can combine cognitive services with infusion, OPAT, specialty drugs, buy-and-bill activity, and hospital-related agreements. These streams may involve different authorization, coding, coverage, and reimbursement requirements. Specialized support helps connect clinical documentation with charge capture, payer rules, claims follow-up, and contract review. It can also help practices identify whether revenue is being lost through undercoding, missing charges, denials, underpayments, or aging accounts.

Relevant support can include eligibility and benefit verification, prior authorization management, medical-versus-pharmacy benefit review, drug and administration claim handling, coding review, denial appeals, payment reconciliation, and aging A/R follow-up. A broader workflow review can also examine the path from referral to first dose and final payment. The appropriate combination depends on how the practice acquires, administers, documents, and bills therapy.

Revenue leakage can be investigated by comparing documented services, charge capture, submitted claims, payer adjudication, expected reimbursement, and posted payments. Useful reporting may organize results by payer, provider, and service line while examining denials, payment trends, underpayments, and aging A/R. For infectious disease practices, the review should include E/M work, infusion administration, drug claims, authorizations, and any contractual or hospital coverage arrangements.

Common causes include missing authorization, medical-versus-pharmacy benefit confusion, drug or administration coding problems, incomplete clinical documentation, unit or NDC mismatches, and payer-specific claim requirements. Denial management is more effective when denials are grouped by root cause rather than handled only as isolated transactions. Payer-specific appeals, documentation review, and feedback to clinical, coding, and front-office teams can help address recurring issues.

A payment review compares the reimbursement received with the amount expected under the applicable payer terms, fee schedule, or agreement. The analysis may examine drug units, NDC information, administration charges, E/M services, and payment posting. Identified short-pays or mismatches can be disputed and tracked through resolution. Contract and coverage agreement review may also show whether reimbursement terms are being applied as intended.

Compare experience with infectious disease workflows, ability to support infusion and OPAT, handling of authorizations and denials, payment reconciliation practices, A/R follow-up, reporting quality, system compatibility, and transparency around assumptions. Practices should also clarify whether the company provides full claims management, overflow support, consulting, or selected services. A useful evaluation connects operational responsibilities with measurable revenue-cycle issues rather than relying on generalized rates or promises.